Search Results 331-340 of 16272 for monoclonal antibody
Regorafenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab or panitumumab, ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of ... No history of severe hypersensitivity to a monoclonal antibody. Signed ...
Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...
Trastuzumab-dttb is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...
A negative serology test means no antibodies were detected in your blood. An antibody test can't find out whether you're currently infected with the COVID-19 ...
... monoclonal antibodies. The dose escalation phase of the study (50, 140, 450 ... She explains that while proteasome inhibitors, immune modulatory drugs and CD38 ...
Monoclonal antibodies, such as varlilumab and nivolumab, may work by stimulating the immune system to attack cancer tumor cells. A Study to Evaluate the Use ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.